Supreme Court

Case: 26-0467    
26-0467
05/08/2026
Mandamus/Cause
IN RE NOVARTIS PHARMACEUTICALS CORPORATION 
 
Appellate Briefs
Date▲▼Event Type▲▼Description▲▼RemarksDocument
11/12/2026Amicus Curiae Brief receivedReceived (instead of filed) Amicus Curiae Brief received on behalf of the Chamber of Commerce of the United States of America. Submitted by Gary M. Dreyer of Dechert LLP of New York, New York.
11/02/2026Brief on the MeritsRelator Relator's Brief on the Merits filed on behalf of Novartis Pharmaceuticals Corporation.
08/13/2026Reply to Petition for Writ of MandamusRelator Reply in Support of Petition for Writ of Mandamus filed on behalf of Novartis Pharmaceuticals Corporation.
08/03/2026Response to Petition for Writ of Mandamus FiledReal Parties in Interest Response to Petition for Writ of Mandamus filed on behalf of State.
08/03/2026Response to Petition for Writ of Mandamus FiledReal Parties in Interest Response to Petition for Writ of Mandamus filed on behalf of Health Selection Goup, LLC.
05/08/2026Petition for Writ of Mandamus filedRelator Petition for Writ of Mandamus filed on behalf of Novartis Pharmaceuticals Corporation.
Case Events
Date▲▼Event Type▲▼Disposition▲▼RemarksDocument
11/12/2026Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Steven A. Engel is granted.
11/12/2026Pro hac vice motion disposedFiling granted Motion of Resident Attorney Gary M. Dreyer in Support of Steven A. Engel's Admission Pro Hac Vice is granted.
11/12/2026Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Michael H. McGinley is granted.
11/12/2026Pro hac vice motion disposedFiling granted Motion of Resident Attorney Gary M. Dreyer in Support of Michael H. McGinley's Admission Pro Hac Vice is granted.
11/12/2026Pro hac vice motion disposed  Motion of Resident Attorney Gary M. Dreyer in Support of Michael H. McGinley's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
11/12/2026Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Michael H. McGinley filed on behalf of Novartis Pharmaceuticals Corporation.
11/12/2026Amicus Curiae Brief received  Amicus Curiae Brief received on behalf of the Chamber of Commerce of the United States of America. Submitted by Gary M. Dreyer of Dechert LLP of New York, New York.
11/11/2026Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Steven A. Engel filed on behalf of Novartis Pharmaceuticals Corporation.
11/11/2026Pro hac vice motion filed  Motion of Resident Attorney Gary M. Dreyer in Support of Steven A. Engel's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
11/02/2026Brief on the Merits  Relator's Brief on the Merits filed on behalf of Novartis Pharmaceuticals Corporation.
10/20/2026Pro hac vice motion disposedFiling granted Motion of Resident Attorney Deron R. Dacus in Support of Abraham Weiss' Admission Pro Hac Vice granted.
10/20/2026Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Abraham Weiss granted.
10/20/2026Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Abraham Weiss filed on behalf of Novartis Pharmaceuticals Corporation.
10/20/2026Pro hac vice motion filed  Motion of Resident Attorney Deron R. Dacus in Support of Abraham Weiss' Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
10/02/2026Motion to withdraw disposed ofFiling granted Motion to Withdraw as counsel is granted.
10/01/2026Notice received  Notice of Nonrepresentation filed on behalf of counsel for Novartis Pharmaceuticals Corporation.
10/01/2026Notice received  Notice of Nonrepresentation filed on behalf of counsel for Novartis Pharmaceuticals Corporation.
10/01/2026Motion to Withdraw Filed  Motion to Withdraw filed on behalf of counsel for Novartis Pharmaceuticals Corporation.
09/30/2026Call received  Call received from counsel for relator regarding procedure for withdrawing a firm as counsel.
09/17/2026Case Summary  Case summary prepared by staff for informational purposes only. Does not reflect the views of the Court.
09/17/2026Motion for Extension of Time disposed.Filing granted Joint Motion for Extension of Time to file Briefs on the Merits granted. Relator's Brief on the Merits is due November 02, 2026. Real Party in Interest's Brief on the Merits is due December 21, 2026. Relator's Reply Brief on the Merits is due January 20, 2027. Absent extraordinary circumstances, further requests for extensions of time for this filing will not be considered.
09/17/2026Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Hagan C. Scotten is granted.
09/17/2026Pro hac vice motion disposedFiling granted Motion of Resident Attorney Deron R. Dacus in Support of Hagan C. Scotten's Admission Pro Hac Vice is granted.
09/17/2026Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Hagan C. Scotten filed on behalf of Novartis Pharmaceuticals Corporation.
09/17/2026Pro hac vice motion filed  Motion of Resident Attorney Deron R. Dacus in Support of Hagan C. Scotten's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
09/17/2026Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Sourabh Mishra’s Admission Pro Hac Vice is granted.
09/17/2026Motion for Extension of Time to File Brief filed  Joint Motion for Extension of Time to file Briefs on the Merits filed on behalf of Novartis Pharmaceuticals Corporation and the State of Texas, et al.
09/17/2026Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Sourabh Mishra is granted.
09/17/2026Pro hac vice motion filed  Motion of Resident Attorney in Support of Sourabh Mishra's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
09/17/2026Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Sourabh Mishra filed on behalf of Novartis Pharmaceuticals Corporation.
09/16/2026Pro hac vice motion disposedFiling granted Motion of Resident Attorney Deron R. Dacus in Support of John C. Hueston's Admission Pro Hac Vice is granted.
09/16/2026Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice of John C. Hueston is granted.
09/16/2026Pro hac vice motion filed  Motion of Resident Attorney Deron R. Dacus in Support of John C. Hueston's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
09/16/2026Pro hac vice motion filed  Motion for Admission Pro Hac Vice of John C. Hueston on behalf of Novartis Pharmaceuticals Corporation.
09/04/2026Brief on the Merits Ordered  Brief on the merits ordered: Relator's brief on the merits due no later than October 5, 2026; Response brief due November 4, 2026; Reply brief due November 19, 2026.
09/04/2026Case set for oral argumentCase set for oral argument This case has been set for oral argument at 9:00 a.m., February 11, 2027. Time allotted to argue: 20/20 minutes
09/04/2026Mandamus Set to Argue 
09/04/2026Petition for Writ of Mandamus disposedCase set for oral argument
08/13/2026Reply to Petition for Writ of Mandamus  Reply in Support of Petition for Writ of Mandamus filed on behalf of Novartis Pharmaceuticals Corporation.
08/04/2026Letter Filed  Letter filed on behalf of Novartis Pharmaceuticals Corporation.
08/03/2026Response to Petition for Writ of Mandamus Filed  Response to Petition for Writ of Mandamus filed on behalf of State.
08/03/2026Response to Petition for Writ of Mandamus Filed  Response to Petition for Writ of Mandamus filed on behalf of Health Selection Goup, LLC.
06/23/2026Motion for Extension of Time to File Response disposedFiling granted Motion for Extension of Time to file Response to Petition for Writ of Mandamus is granted. Response to Petition for Writ of Mandamus is due August 3, 2026. FURTHER REQUESTS FOR EXTENSIONS OF TIME FOR THIS FILING WILL BE DISFAVORED.
06/22/2026Motion for Extension of Time to File Response  Motion for Extension of Time to file Response to Petition for Writ of Mandamus filed on behalf of the State of Texas.
06/05/2026Motion for Extension of Time to File Response disposedFiling granted Motion for Extension of Time to file Response to Petition for Writ of Mandamus is granted. Response is due August 3, 2026. FURTHER REQUESTS FOR EXTENSIONS OF TIME FOR THIS FILING WILL BE DISFAVORED.
06/04/2026Motion for Extension of Time to File Response  Unopposed Motion for Extension of Time to file Response to Petition for Writ of Mandamus filed on behalf of Health Selection Group, LLC.
06/03/2026Notice of Appearance  Notice of Appearance filed on behalf of Health Selection Group, LLC.
06/02/2026Supreme Court of Texas Ordered Response  Court ordered response to petition for writ of mandamus due no later than July 2, 2026.
06/01/2026Reply to Response to Motion  Reply in Support of Motion for Temporary Stay filed on behalf of Novartis Pharmaceuticals Corporation.
05/27/2026Response to Motion filed  Response to Motion to Stay filed on behalf of Health Selection Group.
05/15/2026Pro hac vice motion disposedFiling granted Motion of Resident Attorney Danny S. Ashby in Support of Ross Galin's Admission Pro Hac Vice is granted.
05/15/2026Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice of Ross Galin is granted.
05/15/2026Pro hac vice motion disposedFiling granted Motion of Resident Attorney Danny S. Ashby in Support of Anton Metlitsky's Admission Pro Hac Vice is granted.
05/15/2026Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice of Anton Metlitsky is granted.
05/15/2026Pro hac vice motion filed  Motion of Resident Attorney Danny S. Ashby in Support of Ross Galin's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
05/15/2026Pro hac vice motion filed  Motion for Admission Pro Hac Vice of Ross Galin filed on behalf of Novartis Pharmaceuticals Corporation.
05/15/2026Pro hac vice motion filed  Motion of Resident Attorney Danny S. Ashby in Support of Anton Metlitsky's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
05/15/2026Pro hac vice motion filed  Motion for Admission Pro Hac Vice of Anton Metlitsky on behalf of Novartis Pharmaceuticals Corporation.
05/13/2026Supreme Court of Texas Ordered Response  Court ordered response to Relator's Motion for Temporary Relief due no later than May 27, 2026.
05/13/2026Call received  Call received from Counsel for Relator.
05/08/2026Case Record Filed  Mandamus Record filed on behalf of Novartis Pharmaceuticals Corporation.
05/08/2026Motion to Stay Filed   Motion to Stay filed on behalf of Novartis Pharmaceuticals Corporation.
05/08/2026Petition for Writ of Mandamus filed  Petition for Writ of Mandamus filed on behalf of Novartis Pharmaceuticals Corporation.
Calendars
Set Date▲▼Calendar Type▲▼Reason Set▲▼Remarks▲▼
01/20/2027StatusPet/Rel reply brief on the merits due 
02/11/2027Submission (Set to be Heard)Submission (Set to be heard) 
05/08/2026Motion being reviewed by CourtMotion to stay 
12/21/2026StatusReal party in interest's brief on the merits due 
Parties
Party▲▼Party Type▲▼Representative▲▼
State of TexasReal Party in Interest Mr. Brent Webster
Jonathan D. Bonilla
Ms. Cynthia Lu
Mr. W. Kenneth Paxton
Mr. William Peterson
Ms. Jessica Weltge
Jordan Underhill
Ms. Lynne Kurtz-Citrin
Mr. Evan S. Greene
U.S. Chamber of CommerceAmicus CuriaeGary Dreyer
Health Selection Group, LLCReal Party in Interest Mr. Zeke DeRose III
Honorable Harvey G. Brown Jr.
Mr. Samuel F. Baxter
Mr. Benjamin Major
Mr. Jonathan Wilkerson
Mr. W. Mark Lanier
Ms. Jennifer L. Truelove
Ryan Ellis
Alex J. Brown
Novartis Pharmaceuticals CorporationRelatorMichael H. McGinley
Abraham Weiss
Steven A. Engel
Mr. Deron R. Dacus
John C. Hueston
Megan R. Whisler
Hagan C. Scotten
Court of Appeals Information:
Denied 
740 SW3d 199, 04-30-26 
6th Court of Appeals 
Honorable April Farris 
Trial Court Information
Harrison County Court 
Harrison 
Honorable Brad Morin 
23-0276